A citation-based method for searching scientific literature


List of co-cited articles
11 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



The association between SGLT2 inhibitors and new-onset arrhythmias: a nationwide population-based longitudinal cohort study.
Hung-Yi Chen, Jing-Yang Huang, Wun-Zhih Siao, Gwo-Ping Jong. Cardiovasc Diabetol 2020
36
100

SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials.
Wen-Jie Li, Xing-Qing Chen, Ling-Ling Xu, Yuan-Qing Li, Bi-Hui Luo. Cardiovasc Diabetol 2020
49
100

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis.
Zien Zhou, Meg J Jardine, Qiang Li, Brendon L Neuen, Christopher P Cannon, Dick de Zeeuw, Robert Edwards, Adeera Levin, Kenneth W Mahaffey, Vlado Perkovic,[...]. Stroke 2021
28
100

Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial.
Thomas A Zelniker, Marc P Bonaca, Remo H M Furtado, Ofri Mosenzon, Julia F Kuder, Sabina A Murphy, Deepak L Bhatt, Lawrence A Leiter, Darren K McGuire, John P H Wilding,[...]. Circulation 2020
140
100

SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system.
Benedetta Maria Bonora, Emanuel Raschi, Angelo Avogaro, Gian Paolo Fadini. Cardiovasc Diabetol 2021
20
100

Protective Effects of Sodium-Glucose Transporter 2 Inhibitors on Atrial Fibrillation and Atrial Flutter: A Systematic Review and Meta- Analysis of Randomized Placebo-Controlled Trials.
Daobo Li, Yingying Liu, Tesfaldet Habtemariam Hidru, Xiaolei Yang, Yunsong Wang, Cheng Chen, Ka Hou Christien Li, Yuqi Tang, Yushan Wei, Gary Tse,[...]. Front Endocrinol (Lausanne) 2021
17
100

The risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors.
Ann Wan-Chin Ling, Cze-Ci Chan, Shao-Wei Chen, Yi-Wei Kao, Chien-Ying Huang, Yi-Hsin Chan, Pao-Hsien Chu. Cardiovasc Diabetol 2020
26
100


Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis.
Hang-Long Li, Gregory Y H Lip, Qi Feng, Yue Fei, Yi-Kei Tse, Mei-Zhen Wu, Qing-Wen Ren, Hung-Fat Tse, Bernard-M Y Cheung, Kai-Hang Yiu. Cardiovasc Diabetol 2021
51
100

Efficacy of empagliflozin on heart failure and renal outcomes in patients with atrial fibrillation: data from the EMPA-REG OUTCOME trial.
Michael Böhm, Jonathan Slawik, Martina Brueckmann, Michaela Mattheus, Jyothis T George, Anne Pernille Ofstad, Silvio E Inzucchi, David Fitchett, Stefan D Anker, Nikolaus Marx,[...]. Eur J Heart Fail 2020
40
100

Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation.
Andreas S Papazoglou, Anastasios Kartas, Dimitrios V Moysidis, Christos Tsagkaris, Stavros P Papadakos, Alexandra Bekiaridou, Athanasios Samaras, Efstratios Karagiannidis, Marios Papadakis, George Giannakoulas. Cardiovasc Diabetol 2022
3
50

Meta-analysis Evaluating the Risk of Atrial Fibrillation With Newer Antidiabetics Across the Cardiovascular and Renal Outcome Trials.
Dimitrios Patoulias, Maria Toumpourleka, Christodoulos Papadopoulos, Michael Doumas. Am J Cardiol 2021
6
50

Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer.
A S Abdelmoneim, D T Eurich, P E Light, P A Senior, J M Seubert, M J Makowsky, S H Simpson. Diabetes Obes Metab 2015
53
50




Association of Diabetes With Atrial Fibrillation Phenotype and Cardiac and Neurological Comorbidities: Insights From the Swiss-AF Study.
Arjola Bano, Nicolas Rodondi, Jürg H Beer, Giorgio Moschovitis, Richard Kobza, Stefanie Aeschbacher, Oliver Baretella, Taulant Muka, Christoph Stettler, Oscar H Franco,[...]. J Am Heart Assoc 2021
6
50



Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis.
Naveed Sattar, Darren K McGuire, Imre Pavo, Govinda J Weerakkody, Hiroshi Nishiyama, Russell J Wiese, Sophia Zoungas. Nat Med 2022
22
50


Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysis.
Chao Li, Jie Yu, Carinna Hockham, Vlado Perkovic, Brendon L Neuen, Sunil V Badve, Lauren Houston, Vivian Y J Lee, Jennifer Y Barraclough, Robert A Fletcher,[...]. Diabetes Obes Metab 2022
3
50

Clinical Observation of SGLT2 Inhibitor Therapy for Cardiac Arrhythmia and Related Cardiovascular Disease in Diabetic Patients with Controlled Hypertension.
Shih-Jie Jhuo, Tsung-Hsien Lin, Yi-Hsiung Lin, Wei-Chung Tsai, I-Hsin Liu, Bin-Nan Wu, Kun-Tai Lee, Wen-Ter Lai. J Pers Med 2022
2
50

Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Dipeptidyl Peptidase-4 Inhibitor on the Risks of New-Onset Atrial Fibrillation, Stroke and Mortality in Diabetic Patients: A Propensity Score-Matched Study in Hong Kong.
Sharen Lee, Jiandong Zhou, Keith Sai Kit Leung, Abraham Ka Chung Wai, Kamalan Jeevaratnam, Emma King, Tong Liu, Wing Tak Wong, Carlin Chang, Ian Chi Kei Wong,[...]. Cardiovasc Drugs Ther 2022
2
50


Do GLP-1RAs and SGLT-2is reduce cardiovascular events in women with type 2 diabetes? A systematic review and meta-analysis.
B M Mishriky, V Okunrintemi, S Jain, K A Sewell, J R Powell, D M Cummings. Diabetes Metab 2021
5
50

The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors: a nationwide cohort study.
Yi-Hsin Chan, Tze-Fan Chao, Shao-Wei Chen, Hsin-Fu Lee, Pei-Ru Li, Wei-Min Chen, Yung-Hsin Yeh, Chi-Tai Kuo, Lai-Chu See, Gregory Y H Lip. Cardiovasc Diabetol 2022
1
100




Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF.
Giuseppe Patti, Markus Lucerna, Ilaria Cavallari, Elisabetta Ricottini, Giulia Renda, Ladislav Pecen, Fabio Romeo, Jean-Yves Le Heuzey, Josè Luis Zamorano, Paulus Kirchhof,[...]. J Am Coll Cardiol 2017
58
50

Sodium-Glucose Co-Transporter Inhibitors and Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Arjun K Pandey, Iva Okaj, Hargun Kaur, Emilie P Belley-Cote, Jia Wang, Alireza Oraii, Alexander P Benz, Linda S B Johnson, Jack Young, Jorge A Wong,[...]. J Am Heart Assoc 2021
11
50

Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study).
Omid Fatemi, Eugene Yuriditsky, Costas Tsioufis, Demetrios Tsachris, Timothy Morgan, Jan Basile, Thomas Bigger, William Cushman, David Goff, Elsayed Z Soliman,[...]. Am J Cardiol 2014
100
50

Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus.
Gregoire Fauchier, Arnaud Bisson, Alexandre Bodin, Julien Herbert, Denis Angoulvant, Pierre Henri Ducluzeau, Gregory Y H Lip, Laurent Fauchier. Diabetologia 2021
9
50


Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: observations from TECOS.
Michael A Nauck, Darren K McGuire, Karen S Pieper, Yuliya Lokhnygina, Timo E Strandberg, Axel Riefflin, Tuncay Delibasi, Eric D Peterson, Harvey D White, Russell Scott,[...]. Cardiovasc Diabetol 2019
10
50

Incidence of atrial fibrillation in elderly patients with type 2 diabetes mellitus.
Chisa Matsumoto, Hisao Ogawa, Yoshihiko Saito, Sadanori Okada, Hirofumi Soejima, Mio Sakuma, Izuru Masuda, Masafumi Nakayama, Naofumi Doi, Hideaki Jinnouchi,[...]. BMJ Open Diabetes Res Care 2022
1
100

Stroke in the patient with diabetes (part 1) - Epidemiology, etiology, therapy and prognosis.
David S H Bell, Edison Goncalves. Diabetes Res Clin Pract 2020
8
50

Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes.
Patrícia O Guimarães, Eric D Peterson, Susanna R Stevens, Yuliya Lokhnygina, Jennifer B Green, Darren K McGuire, Rury R Holman, Renato D Lopes. Int J Cardiol 2019
2
50

Impact of diabetes mellitus on mortality rates and outcomes in myocardial infarction.
Volker H Schmitt, Lukas Hobohm, Thomas Münzel, Philip Wenzel, Tommaso Gori, Karsten Keller. Diabetes Metab 2021
12
50

New-Onset Atrial Fibrillation in Patients With Type 2 Diabetes Treated With Novel Glucose-Lowering Therapies.
Fu-Chih Hsiao, Kun-Chi Yen, Tze-Fan Chao, Shao-Wei Chen, Yi-Hsin Chan, Pao-Hsien Chu. J Clin Endocrinol Metab 2022
1
100

Metformin Is Associated With a Lower Risk of Atrial Fibrillation and Ventricular Arrhythmias Compared With Sulfonylureas: An Observational Study.
Anna Ostropolets, Pierre A Elias, Michael V Reyes, Elain Y Wan, Utpal B Pajvani, George Hripcsak, John P Morrow. Circ Arrhythm Electrophysiol 2021
13
50

Effects of Sodium/Glucose Cotransporter Inhibitors on Atrial Fibrillation and Stroke: A Meta-Analysis.
How Ting Ong, Yao Hao Teo, Yao Neng Teo, Nicholas Lx Syn, Caitlin Fern Wee, Shariel Leong, Alicia Swee Yan Yip, Ray Meng See, Adriel Zhi Hen Ting, Alys Zq Chia,[...]. J Stroke Cerebrovasc Dis 2022
6
50

SGLT2 Inhibitors and Their Antiarrhythmic Properties.
Ewald Kolesnik, Daniel Scherr, Ursula Rohrer, Martin Benedikt, Martin Manninger, Harald Sourij, Dirk von Lewinski. Int J Mol Sci 2022
6
50


Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: results from PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04).
Robert Wilcox, Marie-Germaine Bousser, D John Betteridge, Guntram Schernthaner, Valdis Pirags, Stuart Kupfer, John Dormandy. Stroke 2007
334
50

Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort study.
Shilan Seyed Ahmadi, Ann-Marie Svensson, Aldina Pivodic, Annika Rosengren, Marcus Lind. Cardiovasc Diabetol 2020
40
50

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022.
Boris Draznin, Vanita R Aroda, George Bakris, Gretchen Benson, Florence M Brown, RaShaye Freeman, Jennifer Green, Elbert Huang, Diana Isaacs, Scott Kahan,[...]. Diabetes Care 2022
153
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.